Toward a coalition against transfusion-associated GVHD

Transfusion

Volumn 43, Issue 12, 2003, Pages 1655-1657

  Nollet, Kenneth E ^a   Holland, Paul V ^a  

^a BloodSource   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE;

AUTOIMMUNE DISEASE; BLOOD CELL; BLOOD TRANSFUSION; EDITORIAL; GAMMA IRRADIATION; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; IMMUNITY; INCIDENCE; IONIZING RADIATION; JAPAN; LYMPHOCYTE; RACE; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; X RAY;

BLOOD TRANSFUSION; GRAFT VS HOST DISEASE; HUMANS;

EID: 0345598022     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2003.00635.x     Document Type: Editorial

References (20)

1. Aoun E, Shamseddine A, Chehal A, et al. Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center. Transfusion 2003;43:1672-6.
2. Leitman SF, Tisdale JF, Bolan CD, et al. Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosis. Transfusion 2003;43:1667-71.
3. Ohto H, Yasuda H, Noguchi M, Abe R. Risk of transfusion-associated graft-versus-host disease as a result of directed donations from relatives. Transfusion 1992;32:691-3.
4. Petz LD, Calhoun L, Yam P, et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors. Transfusion 1993;33:742-50.
5. Wagner FF, Flegel WA. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes. Transfusion 1995;35:284-91.
6. Ferrara JLM, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-versus-host disease. Biol Blood Marrow Transplant 1999;5:347-56.
7. Asai T, Inaba S, Ohto H, et al. Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan. Transfus Med 2000;10:315-20.
8. Voak D. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. The British Committee for Standards in Hematology. Transfus Med 1996;6:261-71.
9. Standards for blood banks and transfusion services. 22nd ed. Bethesda: American Association of Blood Banks; 2003.
10. Brecher ME, editor. Technical manual. 14th ed. Bethesda: American Association of Blood Banks; 2002.
11. Przepiorka D, LeParc GF, Stovall MA, et al. Use of irradiated blood components: a practice parameter. Am J Clin Pathol 1996;106:6-11.
12. Grass JA, Hei DJ, Metchette K, et al. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood 1998;91:2180-8.
13. Grass JA, Wafa T, Reames A, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999;93:3140-7.
14. Luban NLC. Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components. Semin Hematol 2001;38:34-45.
15. Zelig O, Dacosta Y, Oz D, Mamen N. TA-GVHD following fludarabine treatment in a patient with NHL. Abstracts of the Sixth Regional European Congress of the International Society of Blood Transfusion; 1999 May 9-14; Jerusalem, Israel. p. 128a.
16. Yasukawa M, Shinozaki F, Hato T, et al. Successful treatment of transfusion-associated graft-versus-host disease. Br J Haematol 1994;86:831-6.
17. Nishimura M, Hidaka N, Akaza T, et al. Immunosuppressive effects of chloroquine: potential effectiveness for treatment of post-transfusion graft-versus-host disease. Transfus Med 1998;8:209-14.
18. Juji T, Nishimura M, Tadokoro K. Treatment of post-transfusion graft-versus-host disease. Vox Sang 2000;78 (Suppl 2):277-9.
19. Ryo R, Saigo K, Hashimoto M, et al. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor. Vox Sang 1999;76:241-6.
20. Hutchinson K, Kopko PM, Muto KN, et al. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. Transfusion 2002;42:1567-72.